Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Prescription Drug Costs topic
No spam. Unsubscribe anytime.
Board weighs options to curb prescription drug spending
Summary
The board discussed options to reduce drug costs for the consortium including mandating mail-order maintenance medications through Excellus, pursuing additional rebates, and changing the formulary, but made no formal policy changes at the meeting.
Board members discussed three primary strategies to reduce prescription drug spending for the consortium: mandating mail order for maintenance medications through Excellus, negotiating for greater rebates, and modifying the drug formulary. Those ideas were presented as "things to consider" for 2026 rather than adopted policy.
The conversation framed the proposals as potential levers to address rising medical claims and prescription costs identified in USI—s presentation. Board members did not vote on a specific change at the Jan. 22 meeting and tasked staff and USI with further analysis and possible inclusion on a future agenda.
